Dianthus Therapeutics, Inc. (DNTH) Net income 2016–2025
Dianthus Therapeutics, Inc. (DNTH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$162.3MFY2025 · since FY2016: -$9.4M → -$162.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.3M | -91.1% |
| FY2024 | -$85.0M | -95.1% |
| FY2023 | -$43.5M | -52.9% |
| FY2022 | -$28.5M | -117.2% |
| FY2021 | -$13.1M | +82.5% |
| FY2020 | -$74.9M | +2.4% |
| FY2019 | -$76.8M | -33.5% |
| FY2018 | -$57.5M | -62.1% |
| FY2017 | -$35.5M | -276.3% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice